tm
Seeing Is Believing
tm
Seeing Is Believing
RNAC is currently covered by 5 analysts with an average price target of $33.44. This is a potential upside of $26.76 (400.6%) from yesterday's end of day stock price of $6.68.
Cartesian Therapeutics's activity chart (see below) currently has 61 price targets and 55 ratings on display. The stock rating distribution of RNAC is 93.33% BUY and 6.67% HOLD.
Highest price target for RNAC is $44, Lowest price target is $16, average price target is $33.44.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 29-Sep-2026. First documented stock forecast 11-Mar-2024.
Currently out of the existing stock ratings of RNAC, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-May-2024
$40
$32.64 (443.48%)
$40
9 days ago
(29-Sep-2026)
0/17 (0%)
$32.76 (452.49%)
Buy Since 09-Jul-2025
$38
$30.64 (416.30%)
$38
1 months 20 days ago
(18-Aug-2026)
0/6 (0%)
$28.8 (313.04%)
Buy Since 19-Dec-2024
$44
$34.58 (367.09%)
$44
3 months 29 days ago
(09-Jun-2026)
0/4 (0%)
$37.15 (542.34%)
Buy Since 11-Mar-2024
$25
$17.64 (239.67%)
$30
4 months 26 days ago
(12-May-2026)
0/17 (0%)
$16.3 (187.36%)
Hold Since 09-Mar-2026
$16
$6.58 (69.85%)
$22
6 months 29 days ago
(09-Mar-2026)
0/2 (0%)
$6.98 (77.38%)
Which analyst most recently updated their price target on RNAC (Cartesian Therapeutics)?
Which analyst has the most public recommendations on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most bullish on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most reserved on RNAC (Cartesian Therapeutics)?
